MedPath

Chronic Intermittent Cold Exposure on Weight Loss

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: counseling and behavioral therapy for weight loss
Biological: Whole body cryotherapy
Registration Number
NCT01312090
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

1. To test whether chronic intermittent cold exposure is more effective in programmed body weight loss when compared to conventional programmed weight loss.

2. To measure the metabolic responses (e.g. in the white and brown adipose tissue, muscle and circulating markers) of treatment with chronic intermittent cold exposure and conventional treatment

3. To measure tissue specific changes of weight loss and the treatment with chronic intermittent cold exposure in glucose uptake rate in adipose organ (white and brown adipose tissue), liver, myocardium, skeletal muscle and brain

4. To measure tissue specific biochemical indicators before and after treatment with chronic intermittent cold exposure from white adipose tissue and skeletal muscle.

5. To compare changes in body composition and fat distribution after weight loss using chronic cold exposure or using conventional method

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • BMI > 30 (inclusive)
  • Body weight less than 120 kg
  • Weight stability for 3 months
  • Plasma triglyceride concentration less than 3.0 mmol/l
  • Plasma HDL-cholesterol more than 0.9 mmol/l in males and more than 1.0 mmol/l in females
  • Blood pressure less than 140/90 mmHg (inclusive)
  • Normal glucose tolerance or impaired glucose tolerance but not diabetes (fasting glucose < 7.0 mmol/l or 2 h glucose in the oral glucose tolerance test < 11.1 mmol/l)
Exclusion Criteria
  • Smoking
  • Frequent weight loss attempts
  • Pregnancy or lactation
  • Diabetes mellitus
  • Hypo/hyperthyreosis
  • Cardiovascular disease, stroke or neurological disorder
  • Medication (antihypertensive and antidiabetic drugs, lipid lowering drugs, antidepressants, corticosteroids)
  • Claustrophobia
  • Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results.
  • Presence of any ferromagnetic objects that would make MRI imaging contraindicated

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional weight loss treatment groupcounseling and behavioral therapy for weight lossEating and physical activity counseling and behavioral therapy for weight loss.
Cryo groupWhole body cryotherapyEating and physical activity counseling and behavioral therapy for weight loss will be provided to all subjects. The subjects in the cryo group will be given whole-body cryotherapy 1-3 times a week for the 4-month-treatment period
Primary Outcome Measures
NameTimeMethod
weight losslooking forward using periodic observations collected predominantly during 12 months following subject enrollment

Effect of chronic intermittent cold exposure and conventional treatment on weight loss

Secondary Outcome Measures
NameTimeMethod
Glucose uptake4 months from admission

Effect of chronic intermittent cold exposure and conventional treatment on glucose uptake of brown and white adipose tissue, liver, myocardium, skeletal muscle and brain (PET-scan).

energy metabolism12 months from admission

Effect of chronic intermittent cold exposure and conventional treatment on energy metabolism

behavioural patterns12 months from admission

Effect of chronic intermittent cold exposure and conventional treatment on behavioural patterns

muscle metabolism12 months from admission

Effect of chronic intermittent cold exposure and conventional treatment on muscle metabolism

white adipose tissue metabolism12 months from admission

Effect of chronic intermittent cold exposure and conventional treatment on white adipose tissue metabolism

© Copyright 2025. All Rights Reserved by MedPath